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Abstract
Background: The diabetes mellitus cascade of care has been constructed to evaluate diabetes care at a population level by
determining the percentage of individuals diagnosed and linked to care as well as their reported glycemic control.
Objective: We sought to adapt the cascade of care to an inpatient-only setting using the electronic health record (EHR) data of
81,633 patients with type 2 diabetes.
Methods: In this adaptation, linkage to care was defined as prescription of diabetes medications within 3 months of discharge,
and control was defined as hemoglobin A1c (HbA1c) below individual target levels, as these are the most reliably captured items
in the inpatient setting. We applied the cascade model to assess differences in demographics and percent loss at each stage of the
cascade; we then conducted two-sample chi-square equality of proportions tests for each demographic. Based on findings in the
previous literature, we hypothesized that women, Black patients, younger patients (<45 years old), uninsured patients, and patients
living in an economically deprived area called the Promise Zone would be disproportionately unlinked and uncontrolled. We also
predicted that patients who received inpatient glycemic care would be more likely to reach glycemic control.
Results: We found that out of 81,633 patients, 28,716 (35.2%) were linked to care via medication prescription. Women and
younger patients were slightly less likely to be linked to care than their male and older counterparts, while Black patients (n=19,141,
23.4% of diagnosed population vs n=6741, 23.5% of the linked population) were as proportionately part of the linked population
as White patients (n=58,291, 71.4% of diagnosed population vs n=20,402, 71.0% of the linked population). Those living in
underserved communities (ie, the Promise Zone) and uninsured patients were slightly overrepresented (n=6789, 8.3% of diagnosed
population vs n=2773, 9.7% of the linked population) in the linked population as compared to patients living in wealthier zip
codes and those who were insured. Similar patterns were observed among those more likely to reach glycemic control via HbA1c.
However, conclusions are limited by the relatively large amount of missing glycemic data.
Conclusions: We conclude that inpatient EHR data do not adequately capture the care cascade as defined in the outpatient
setting. In particular, missing data in this setting may preclude assessment of glycemic control. Future work should integrate
inpatient and outpatient data sources to complete the picture of diabetes care.
(JMIR Diabetes 2022;7(1):e27486) doi: 10.2196/27486
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Introduction

subsequent follow-up periods as well [12]. While diabetes is
seldom the primary focus of an inpatient admission, a
hospitalization is nonetheless an opportunity for diabetes
diagnosis and linkage to care, and this has not been thoroughly
studied. Therefore, we sought to address this gap in the literature
by examining a proposed inpatient cascade of diabetes care for
patients with type 2 diabetes. This paper provides a construction
and analysis of this framework by examining patients who were
initially diagnosed in the inpatient setting and their linkage to
care during their stay. Additionally, we assessed for disparities
in care according to the demographic and socioeconomic
characteristics of patients.

A total of 34 million patients in the United States are currently
diagnosed with diabetes mellitus, which equates to roughly 10%
of the population. Diabetes was the seventh leading cause of
death in 2017. Type 2 diabetes is further complicated by
comorbidities, such as high blood pressure, cholesterol, and
cardiovascular disease (CVD) [1], and accounts for roughly US
$327 billion per year in the US health care system [2].
Overall, new cases of diabetes have been decreasing over the
last decade, even among younger patients, while disparities by
both race and education level were noted in the US Centers for
Disease Control and Prevention’s 2017 diabetes report. The
report indicated that Hispanic, Black, and Native American and
Alaska Native patients had a higher prevalence of diabetes
compared to White patients. Additionally, diabetes was almost
twice as prevalent among adults without a high school diploma
in contrast to adults who at least graduated and pursued further
degrees [3]. It has been shown that Black patients receiving
Medicare are also less likely than those not covered by Medicare
to report well-controlled blood sugar [4], and women diagnosed
with diabetes face increased risk of cardiac and kidney
comorbidities compared to men [5].
The cascade of diabetes care exists to examine the treatment
path from diagnosis to linkage to care for diabetes patients
through follow-up visits with their primary care provider,
prescription of diabetes medications, and visits with diabetes
or nutritional specialists. Diabetes control refers to adherence
to quality-of-care metrics, including hemoglobin A1c (HbA1c)
measurements below individualized target levels, controlled
systolic and diastolic blood pressure, assessment of lipids and
urine microalbumin, and nonsmoking status.
Using National Health and Nutrition Examination Survey data
from 2005 to 2016, previous research found that 70% of patients
were linked to care, while just 20% of patients reached the
composite treatment targets [6]. They reported that diabetes
care, in terms of linkage to care and control, had not improved
significantly from 2005-2006 to 2015-2016, nor were there
improvements in disparities in linkage to care and disease
control between sexes, races, and age groups. Younger patients
and female patients were consistently less likely to be linked to
care after their diagnosis. In addition, younger, female,
non-White, and Hispanic patients were less likely to reach
glycemic control, blood pressure, and cholesterol targets than
their older, male, White, and non-Hispanic counterparts [7].
These disparities have been explored in previous studies
compiled by the American Journal of Public Health [8] and
have been tied to different behavioral factors, such as stress and
substance abuse; psychological factors, such as depression; and
clinical factors, such as quality of care and timely diagnosis and
treatment.
According to the American Diabetes Association (ADA),
roughly one-third of health care costs associated with diabetes
are related to hospital inpatient care [9]. Basal-bolus insulin
regimens for inpatient glycemic control have been shown to
reduce hospital complications, particularly for postsurgical
patients [10,11], with potentially improved glycemic control in
https://diabetes.jmir.org/2022/1/e27486
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Methods
Study Population
Our study population was comprised of 93,433 patients with
diabetes who were seen in the inpatient setting of a 15-hospital
health care system in St. Louis, Missouri, from 2010 to 2019.
We focused our study on individuals with or without
complications of diabetes, and we excluded those diagnosed
with diabetes during pregnancy (International Classification of
Diseases, Tenth Revision [ICD-10] O24.xx, n=3875).
Additionally, we excluded patients with type 1 diabetes (ICD-10
E10.xx, n=7925) from our study, given our objective to focus
on those diagnosed with type 2 diabetes. We also focused on
only those for which the diagnosis of type 2 diabetes appeared
in the problem list for that admission. Our final study population
included 81,633 patients.

Constructing the Inpatient Cascade of Care
We consulted published guidelines from the ADA [9,10,13]
with input from an endocrinologist (CH) to adapt the outpatient
cascade of care [6] for the inpatient setting. Data were procured
from the electronic health records (EHRs) of a large St. Louis,
Missouri–area medical center. For the inpatient cascade, patients
were considered diagnosed, linked to care, or controlled based
on the following:
•

•

•

Patients were considered diagnosed if they had a diagnosis
of type 2 diabetes mellitus, with or without complications
(ICD-10 E11.xx), and were admitted to the hospital system
with their first recorded diabetes diagnosis in the problem
list within a day of diagnosis.
Patients were considered linked to care if they were
prescribed insulin, noninsulin injectables, or oral
anti-diabetes drugs (Multimedia Appendix 1) within 3
months of discharge.
Patients were considered controlled if their recorded HbA1c
6 months after discharge was between 7% and 8.5%. This
definition was individualized per existing guidelines and
the previously published outpatient cascade of care [6].
•
Patients less than 65 years of age were considered
controlled (HbA1c≤7%) if they had diabetes without
complications or CVD, and were considered controlled
(HbA1c≤8%) if they had complications or CVD.
•
Patients 65 years of age or older were considered
controlled (HbA1c≤7.5%) if they had diabetes without
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complications or CVD, and were considered controlled
(HbA1c≤8.5%) if they had complications or CVD.

Variables of Interest
Our population was mainly White, consistent with the population
in the St. Louis metropolitan area. Thus, we categorized race
into categories of White, Black, and other. We defined age
groups according to the following cutoffs: 18 to 44 years, 45 to
64 years, and 65 years of age and older [6]. Patients with
self-pay insurance or no recorded insurance were considered
uninsured, and patients with insurance that did not include
Medicare or Medicaid were considered privately insured.
We classified the zip code of residence for each patient
according to whether or not they lived in the Promise Zone. The
Promise Zone is an area in North St. Louis City and County
designated in 2015 that is defined by a poverty rate or extremely
low–income rate equal to or greater than 33% of the federal
poverty level, where a federal local partnership has been
established to improve education, economic activity, health,
and wellness in the community [14].
To assess which HbA1c control cutoff to use, we considered
patients’ diabetes diagnoses, as well as any CVD diagnoses as
previously described, and the patients’ ages. Our definition of
CVD included myocardial infarction, heart failure, and angina
(Multimedia Appendix 1). Finally, as a proxy to evaluate if and
how diabetes was recognized in the inpatient setting (ie,
inpatient glycemic care indicator), we assessed whether HbA1c
was measured, whether insulin lispro was administered within
24 hours of their admission, or whether a consultation with a
diabetes or endocrinology specialist was called at any point
during their admission.

Analysis
We constructed descriptive statistics of the distributions of race,
sex, and age at diagnosis, as well as insurance status, residence
in the Promise Zone, and inpatient glycemic care indicators:
HbA1c, insulin, and diabetes consultation in our data set. We
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then compared proportions within each category along the
cascade of care to assess disparities using two-sample chi-square
tests.
We explored geographic disparities in the data and compared
the cascade of diabetes care for patients who lived in Promise
Zone zip codes to those residing in the remaining zip codes in
the patient catchment area.

Hypotheses
We hypothesized that patients living in Promise Zone zip codes
and those with self-pay insurance or on Medicaid would be less
likely to be linked to care and to reach HbA1c control.
Additionally, we hypothesized that patients who had an inpatient
glycemic care indicator would be more likely to be linked but
less likely to be controlled, as those patients may be more severe
cases to begin with to require inpatient insulin treatment. From
findings in the previous literature, we hypothesized that women,
Black patients, and younger patients would be disproportionately
unlinked and uncontrolled [7].

Ethical Considerations
This study was approved by the Washington University St.
Louis Institutional Review Board (IRB) as an “exempt” project.
The IRB ID for this project was 202007104.

Results
Overview
In our data set, 81,633 patients met the inclusion criteria. Our
study population was 48.9% (n=39,880) female, 51.1%
(n=41,748) male, and predominately White (n=58,291, 71.4%)
and older (≥65 years of age: n=46,860, 57.4%; Table 1). A total
of 35.5% (n=28,997) of patients were privately insured and
38.9% (n=31,742) received Medicare. A total of 17.5%
(n=14,309) of patients resided in a Promise Zone zip code (Table
1), compared to 8% of the general St. Louis metropolitan
population (data not shown).
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Table 1. Demographic and clinical characteristics of our study population.
Variable

Participants (N=81,633), n (%)

Sex
Female

39,880 (48.9)

Male

41,748 (51.1)

Missing

5 (<1.0)

Race
White

58,291 (71.4)

Black

19,141 (23.4)

Other

2625 (3.2)

Missing

1576 (1.8)

Age at diagnosis (years)
18-44

5887 (7.2)

45-64

28,886 (35.4)

≥65

46,860 (57.4)

Missing

4 (<1.0)

Residence in Promise Zone

14,309 (17.5)

Insurance status
Private

28,997 (35.5)

Medicare

31,742 (38.9)

Medicaid

14,096 (17.3)

Uninsured or self-pay

6798 (8.3)

Missing

4 (<1.0)

Inpatient glycemic care markers

a

HbA1ca measured within 24 hours

22,337 (27.4)

Insulin lispro administered within 24 hours

59,220 (72.5)

Diabetes or endocrinology specialist consultation during stay

4988 (6.1)

At least one glycemic care marker

63,222 (77.4)

HbA1c: hemoglobin A1c.

The Inpatient Cascade of Care
Out of 81,633 patients in our data set, 35.2% (n=28,716) met
the linkage-to-care criteria for medication prescription within
3 months of discharge. Figure 1 shows the proportion of patients
achieving each of the stages in the cascade of care, stratified by
linked and unlinked to care, and then by in control, not in
control, and missing a measure of HbA1c. A total of 70.4% of
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patients (n=57,495) had no HbA1c values recorded in the
inpatient setting 6 months after their initial admission. While
this is a large proportion of missing values, we recognize that
after an initial inpatient encounter, diabetes patients generally
transition into outpatient settings for their continued care.
Therefore, these values may not be recorded in inpatient EHR
records.

JMIR Diabetes 2022 | vol. 7 | iss. 1 | e27486 | p. 4
(page number not for citation purposes)

JMIR DIABETES

Ryan et al

Figure 1. This flowchart illustrates the cascade of type 2 diabetes care with cohort sizes at each stage of the cascade, including information about
missing glycemic data. Note, the control row of the flowchart indicates the percentage of the linked or unlinked cohorts, not the percentage of the original
diagnosed cohort. HbA1c: hemoglobin A1c.

In our data, females and younger patients were less likely to be
linked to care compared to males and middle-aged patients.
Women made up 48.9% (n=39,880) of the diagnosed population,
but 48.9% (n=13,814) of the linked population (<1% change,
P=.03). Younger patients made up 7.2% (n=5887) of the entire
diagnosed population, but were just 6.8% (n=1963) of the linked
population (<1% change, P=.03). We did not find that patient
race varied between the diagnosed, linked, and unlinked
populations. Patients living in the Promise Zone (n=14,309,
17.5% of diagnosed population vs n=5366, 18.7% of linked
population; P<.001) and uninsured patients (n=6798, 8.3% vs
n=2773, 9.7%; P<.001) were more likely to be linked to care,
while those with private insurance were less likely to be linked
to care (n=28,997, 35.5% vs n=9611, 33.5%; P<.001).
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Differences in HbA1c control among individuals linked to care
must be interpreted with caution in the setting of missing data.
Among those linked to care, patients 65 years of age and older
and men were less likely to be uncontrolled compared to
younger patients and women. Black patients were
overrepresented in the uncontrolled group, but they were also
less likely to be missing a recorded HbA1c value at 6 months as
measured in the inpatient setting. While patients in the Promise
Zone were more likely to be linked to care, approximately
one-third (n=1612, 30.0% of linked patients residing in the
Promise Zone) of those patients reached HbA1c control. Finally,
individuals with self-pay insurance and those on Medicaid were
less likely to be controlled but were also less likely to be missing
HbA1c data over the course of the 6-month follow-up window.
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Table 2. Cascade of care by population covariates.
Variable

Diagnosed
(N=81,633),

Linked to care
(n=28,716),

Unlinked to care
(n=52,917),

n (%)

n (%)

n (%)

Linked to care, n (%)a

Controlled
b

HbA1c (n=7076)

Uncontrolled
HbA1c (n=4148)

Missing HbA1c
(n=17,492)

Sex
Female

39,880 (48.9)

13,814 (48.1)*

26,066 (49.3)

3592 (50.8)*

2102 (50.7)*

8120 (46.4)*

Male

41,748 (51.1)

14,902 (51.9)*

26,846 (50.7)

3484 (49.2)*

2046 (49.3)*

9372 (53.6)*

Missing

5 (<1.0)

0 (0)

5 (<1.0)

0 (0)

0 (0)

0 (0)

White

58,291 (71.4)

20,402 (71.0)

37,889 (71.6)

4789 (67.7)*

2584 (62.3)*

13,029 (74.5)*

Black

19,141 (23.4)

6741 (23.5)

12,400 (23.4)

2012 (28.4)*

1418 (34.2)*

3311 (18.9)*

Other

2625 (3.2)

1001 (3.5)*

1624 (3.1)

246 (3.0)

109 (2.6)

679 (3.9)*

Missing

1576 (1.8)

572 (1.9)

1004 (1.9)

74 (<1.0)

32 (<1.0)

473 (2.7)*

18-44

5887 (7.2)

1963 (6.8)*

2924 (7.4)*

349 (4.9)*

516 (12.4)*

1098 (6.3)*

45-64

28,886 (35.4)

10,397 (36.2)*

18,489 (34.9)

2376 (33.6)*

2130 (51.4)*

5891 (33.7)*

≥65

46,860 (57.4)

16,356 (57.0)

30,504 (57.6)

4351 (61.5)*

1502 (36.2)*

10,503 (60.0)*

14,309 (17.5)

5366 (18.7)*

8943 (16.9)*

1612 (22.9)*

847 (28.5)*

2661 (15.2)*

Private

28,997 (35.5)

9611 (33.5)*

19,386 (36.6)*

1937 (27.4)*

1140 (38.4)*

6145 (35.1)*

Medicare

31,742 (38.9)

11,487 (40.0)*

20,255 (38.2)*

3132 (44.3)*

731 (24.6)*

7152 (40.9)

Medicaid

14,096 (17.3)

4845 (16.9)

9251 (17.5)

1261 (17.8)

583 (19.6)*

2813 (16.1)*

Self-pay

6798 (8.3)

2773 (9.7)*

4025 (7.6)*

746 (10.5)*

515 (17.3)*

1382 (7.9)*

HbA1c measured within 22,337 (27.4)
24 hours

8255 (28.7)*

14,082 (26.6)*

1979 (28.0)*

1390 (33.5)*

4886 (27.9)

Insulin lispro administered within 24 hours

23,003 (80.1)*

36,217 (68.4)*

5589 (79.0)*

3649 (88.0)*

13,765 (78.7)*

Diabetes or endocrinol- 4988 (6.1)
ogy specialist during
stay

2335 (8.1)*

2654 (5.0)*

737 (10.4)*

687 (16.5)*

910 (5.2)*

At least one inpatient
glycemic care marker

24,159 (84.1)*

39,064 (73.8)*

5937 (83.9)

3800 (91.6)*

14,421 (82.4)*

Race

Age at diagnosis (years)

Residence in Promise Zone
Insurance status

Inpatient glycemic care markers

a

59,220 (72.5)

63,222 (77.4)

Proportions in the glycemic control columns denote the proportion of linked patients, not of the entire diagnosed population.

b

HbA1c: hemoglobin A1c.
*P<.05 between proportions from one stage of the cascade to the next.

Patients with inpatient glycemic care markers were more likely
to be linked to care. For example, 72.5% (n=59,220) of the
diagnosed population were administered insulin lispro within
24 hours, and those patients made up 80.1% (n=23,003) of the
linked cohort versus 68.4% (n=36,217) of the unlinked cohort
(P<.001). Additionally, 77.4% (n=63,222) of patients in the
diagnosed population had at least one inpatient glycemic care
indicator, and these patients were also overrepresented in the
linked population (linked: n=24,159, 84.1% vs unlinked:
n=39,064, 73.8%; P<.001). However, individuals with at least
one glycemic care indicator were overrepresented in the
https://diabetes.jmir.org/2022/1/e27486
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uncontrolled population (uncontrolled: n=3800, 91.6% vs
controlled: n=5937, 83.9%; P<.001).

Discussion
Principal Findings
The analysis in this study is a first step in using inpatient EHR
data to explore the diabetes cascade of care in an inpatient
setting. Among a population of individuals with type 2 diabetes
diagnoses newly noted during hospital admission, we were able
to determine how many were linked to care using a definition
JMIR Diabetes 2022 | vol. 7 | iss. 1 | e27486 | p. 6
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of diabetes medication prescription within 3 months of
discharge. We were able to determine indicators of inpatient
glycemic management (ie, HbA1c checked, insulin started, or
diabetes service consulted) and identified that individuals with
one or more of these indicators were significantly more likely
to be linked to care. Our findings highlight the importance of
recognizing diabetes during a hospital stay in establishing
appropriate follow-up.
We observed that a significant proportion of individuals treated
with insulin lispro during a hospital stay did not meet criteria
for linkage to care, identifying a potential opportunity for
intervention. In addition, very few patients were seen by a
diabetes or endocrinology specialist in the hospital; however,
this is not unexpected given that diabetes consultations, when
available at a particular hospital, are typically reserved for only
the most severely uncontrolled patients. We also examined
HbA1c values at 6 months postdischarge; however, conclusions
about control were limited by significant missingness in the
data, and these associations should be explored with more
complete data in the future.
Our analysis highlights three important points: (1) a possible
“leaky pipeline,” or patients that drop out of the cascade of care
after discharge from the hospital; (2) the importance of
recognizing and acting on diabetes in the inpatient setting to
mitigate this leaky pipeline; and (3) the difficulty of using
inpatient data alone for the definition of a diabetes cascade of
care.

Linkage to Care, Leaky Pipeline, and Inpatient
Glycemic Care Markers
First, we noted that only 35% of the population was linked to
care by our definition of receiving medication for diabetes within
3 months of discharge. This likely overestimates loss to
follow-up; however, because 19% of patients in the unlinked
group were noted to have a controlled HbA1c at 6 months
postdischarge, these patients were likely linked to outpatient
care. Nonetheless, even if those who were linked to care and
those who were unlinked but controlled were considered
together, they would comprise 54% of the population. This
proportion is much lower than the 77% who met one of the
inpatient glycemic care indicators in the inpatient setting.
We observed that patients with at least one of the inpatient
glycemic care markers were much more likely to be linked to
care than those without, underscoring the importance of
recognizing and acting on diabetes during a hospital stay.
Additionally, and not surprisingly, at 6 months postdischarge,
a larger proportion of individuals who were linked to care had
controlled HbA1c as compared to those not linked to care, and
a smaller proportion of those who were linked to care had
missing HbA1c data as compared to those not linked to care.
We hypothesized that while patients with inpatient glycemic
care markers were more likely to be linked to care, they would
also be less likely to reach their HbA1c target at 6 months,
possibly representing diabetes that is more difficult to control.
Counter to our hypothesis, patients with no insurance were more
likely to be linked to care, and patients with private insurance
https://diabetes.jmir.org/2022/1/e27486
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were less likely to be linked. Meanwhile, patients living in the
Promise Zone were more likely to be linked to care as compared
to those not residing in the Promise Zone. These findings were
unexpected but could reflect the type of follow-up data available
within our hospital system. Privately insured individuals and
those living in zip codes with higher economic opportunity may
be more likely to follow up with a physician outside of our
system, whereas uninsured patients and those living in the
Promise Zone may be more likely to be readmitted to our system
as an inpatient during the follow-up period.

Glycemic Control Assessment and Data Missingness
Data missingness refers to the prevalence of data not captured
in the inpatient EHR. Black patients, younger patients, patients
with no insurance, or those receiving Medicaid were
overrepresented in the uncontrolled population as compared
with the overall diagnosed population; however, these groups
were also less likely to be missing HbA1c data than their
comparators, so it is difficult to draw firm conclusions with this
information. The lower proportion of missing HbA1c data among
these populations may be related to these populations being
seen in the inpatient setting more often; thus, their data were
better captured.

Difficulty Defining Diabetes Cascade of Care With
Inpatient Data Alone
Overall, our analysis demonstrates that defining a cascade of
diabetes care using inpatient data alone is limited by the
fragmentation in the health care ecosystem. Given that diabetes
is managed almost exclusively in the outpatient setting, the
utility of an inpatient diabetes cascade of care would be
primarily to (1) determine appropriate management of
hyperglycemia in the inpatient setting for individuals with
diabetes and (2) identify newly diagnosed diabetes and action
by the inpatient team to prescribe appropriate therapy and
connect the patient to an outpatient provider upon discharge.
Our analysis highlights a challenge commonly encountered in
the United States, in that inpatient data may not be linked to
outpatient data, even within a network of affiliated outpatient
practices in a hospital system [15,16]. Interoperability of EHR
systems is critical to optimize this type of analysis in the future.

The “Ideal” Inpatient Cascade of Diabetes Care
An optimal investigation of a diabetes cascade of care would
focus on diabetes first noted in the inpatient setting and
identifying individuals first noted in a hospital stay to have
glucose values outside of the normal range. The next steps would
be to determine what proportion of these individuals
subsequently had an HbA1c evaluation, and then to quantify
how many of those diagnosed with diabetes via an HbA1c value
equal to or more than 6.5% were initiated on diabetes medication
and referred to a primary care provider for follow-up. Such an
investigation would also include detailed glucose data during
the hospital stay to determine what proportion of individuals
with blood sugars greater than 180 mg/dL in the inpatient setting
were started on insulin during the hospital stay and how many
had a diabetes consultation in the hospital. The cascade would
then follow individuals in the outpatient setting to determine
how many ultimately achieved glycemic control, blood pressure,
JMIR Diabetes 2022 | vol. 7 | iss. 1 | e27486 | p. 7
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cholesterol, and smoking targets, which are associated with
CVD risk among patients with diabetes. The benefit of using
fully integrated inpatient and outpatient EHR data for this type
of analysis lies in the potential for longitudinal follow-up and
the opportunity to identify individuals most severely affected
by complicated diabetes who are hospitalized.

System-Level Challenges in Transition of Care From
Inpatient to Outpatient Settings
The lack of interoperability between inpatient and outpatient
EHR systems creates significant opportunities for loss to
follow-up in clinical care. Hospital discharge summaries may
not reach the primary care physician, and they may not
specifically address diabetes if this was not the reason for
admission [17,18]. Moreover, enhanced diabetes education in
the inpatient setting with specific transition instructions provided
to the patient and primary care physician improved HbA1c over
a 1-year follow-up [19]. However, inpatient diabetes
self-management education is not a reimbursed service, and
outpatient access to certified diabetes education is limited [20].
Diabetes-specific structured communication between inpatient
and outpatient providers is essential to improve diabetes
follow-up along the cascade of care.

Limitations

Ryan et al
in the high number of missing HbA1c measures due to the
limitations of inpatient EHR data that we had access to for the
analysis. Additionally, we pulled the first inpatient admission
of diabetes mellitus based on the problem list for each patient,
which means they could have been diagnosed earlier in the
outpatient or primary care setting and received linkage to care
for their diabetes in another setting not captured in our analysis.

Conclusions
An inpatient encounter may be an opportunity for incidental
diabetes diagnosis, treatment, and linkage to care. However, a
cascade of diabetes care using inpatient data alone is insufficient
and difficult to align with the outpatient cascade of diabetes
care [6] because of differences in care delivery and guidelines
between the two settings. Additionally, we noted that while
there were statistically significant differences between
demographic variables of sex, race, age, insurance, and
socioeconomic status indicated by residence in the Promise
Zone and patients’ linkage to care and glycemic control, those
relationships may not be clinically significant. We recommend
further study using integrated EHR data from inpatient and
outpatient settings to define a cascade of care across the
continuum of care to better define the utility of the inpatient
setting in capturing and linking individuals with diabetes to
appropriate outpatient care.

Significant limitations exist in the study, as outlined in the
previous section, in part due to fragmentation. This is evidenced
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